These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38968642)

  • 1. Peripheral artery disease, chronic kidney disease, and recurrent admissions for acute decompensated heart failure: The ARIC study.
    Chunawala ZS; Bhatt DL; Qamar A; Vaduganathan M; Mentz RJ; Matsushita K; Grodin JL; Pandey A; Caughey MC
    Atherosclerosis; 2024 Aug; 395():118521. PubMed ID: 38968642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Admissions for Acute Decompensated Heart Failure Among Patients With and Without Peripheral Artery Disease: The ARIC Study.
    Chunawala Z; Chang PP; DeFilippis AP; Hall ME; Matsushita K; Caughey MC
    J Am Heart Assoc; 2020 Nov; 9(21):e017174. PubMed ID: 33100106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral artery disease and risk of kidney outcomes: The Atherosclerosis Risk in Communities (ARIC) study.
    Paskiewicz A; Wang FM; Ishigami J; Pang Y; Sang Y; Ballew SH; Grams ME; Heiss G; Coresh J; Matsushita K
    Atherosclerosis; 2024 Oct; 397():118558. PubMed ID: 39276420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Artery Disease: Its Adverse Consequences With and Without CKD.
    Bourrier M; Ferguson TW; Embil JM; Rigatto C; Komenda P; Tangri N
    Am J Kidney Dis; 2020 May; 75(5):705-712. PubMed ID: 31879218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure.
    Manzano-Fernández S; Flores-Blanco PJ; Pérez-Calvo JI; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Galisteo-Almeda L; Pascual-Figal D; Valdes M; Januzzi JL
    J Card Fail; 2013 Aug; 19(8):583-91. PubMed ID: 23910589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
    Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
    Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.
    Bansal N; Zelnick L; Bhat Z; Dobre M; He J; Lash J; Jaar B; Mehta R; Raj D; Rincon-Choles H; Saunders M; Schrauben S; Weir M; Wright J; Go AS;
    J Am Coll Cardiol; 2019 Jun; 73(21):2691-2700. PubMed ID: 31146814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease.
    Smilowitz NR; Bhandari N; Berger JS
    Atherosclerosis; 2020 Mar; 297():149-156. PubMed ID: 31948675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of estimated glomerular filtration rate with outcomes following infrainguinal bypass for peripheral arterial disease.
    Naazie IN; Mwinyogle A; Nejim B; Al-Nouri O; Cajas-Monson L; Malas MB
    J Vasc Surg; 2021 Sep; 74(3):788-797.e1. PubMed ID: 33647436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study.
    Chunawala ZS; Qamar A; Arora S; Pandey A; Fudim M; Vaduganathan M; Bhatt DL; Mentz RJ; Caughey MC
    J Card Fail; 2022 Aug; 28(8):1267-1277. PubMed ID: 35045321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).
    Chang PP; Chambless LE; Shahar E; Bertoni AG; Russell SD; Ni H; He M; Mosley TH; Wagenknecht LE; Samdarshi TE; Wruck LM; Rosamond WD
    Am J Cardiol; 2014 Feb; 113(3):504-10. PubMed ID: 24342763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKD and Acute and Long-Term Outcome of Patients with Peripheral Artery Disease and Critical Limb Ischemia.
    Lüders F; Bunzemeier H; Engelbertz C; Malyar NM; Meyborg M; Roeder N; Berger K; Reinecke H
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):216-22. PubMed ID: 26668023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Unger ED; Dubin RF; Deo R; Daruwalla V; Friedman JL; Medina C; Beussink L; Freed BH; Shah SJ
    Eur J Heart Fail; 2016 Jan; 18(1):103-12. PubMed ID: 26635076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study).
    Chunawala ZS; Fudim M; Arora S; Qamar A; Vaduganathan M; Mentz RJ; Pandey A; Caughey MC
    Am J Cardiol; 2021 Nov; 158():59-65. PubMed ID: 34474908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and acute-on-chronic kidney injury of patients with decompensated heart failure: impact on outcomes.
    Zhou Q; Zhao C; Xie D; Xu D; Bin J; Chen P; Liang M; Zhang X; Hou F
    BMC Nephrol; 2012 Jul; 13():51. PubMed ID: 22747708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.
    Smith DH; Thorp ML; Gurwitz JH; McManus DD; Goldberg RJ; Allen LA; Hsu G; Sung SH; Magid DJ; Go AS
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):333-42. PubMed ID: 23685625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease.
    Uemura Y; Shibata R; Takemoto K; Uchikawa T; Koyasu M; Ishikawa S; Mitsuda T; Miura A; Imai R; Iwamiya S; Ozaki Y; Kato T; Miura T; Watarai M; Murohara T
    Heart Vessels; 2016 Oct; 31(10):1643-9. PubMed ID: 26615607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
    Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
    Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.